Asthma

Introdcuction

The airways become obstructed from either inflammation of the lining of the air-
ways or constriction of the bronchial smooth muscles (bronchospasm). A known
allergen, for example, pollen—is inhaled, causing activation of antibodies that rec-
ognize the allergen. Mast cells and histamine are activated, initiating a local inflam-
matory response. Prostaglandins enhance the effect of histamine. Leukotrienes also
respond, enhancing the inflammatory response. White blood cells responding to the
area release inflammatory mediators.
Astimulus causes an inflammatory reaction, increasing the size of the bronchial
linings; this results in restriction of the airways. There may be a bronchial smooth
muscle reaction at the same time. There are two kinds of asthma:
• Extrinsic asthma, also known as atopic, caused by allergens such as pollen,
animal dander, mold, or dust. Often accompanied by allergic rhinitis and
eczema; this may run in families.
• Intrinsic asthma, also known as nonatopic, caused by a nonallergic factor
such as following a respiratory tract infection, exposure to cold air, changes
in air humidity, or respiratory irritants.

PROGNOSIS
Triggers for the asthmatic patient can often be identified and avoided. Patients can
learn to check peak flow levels and manage symptoms in conjunction with their
caregiver. Well controlled asthma typically has temporary, reversible exacerba-
tions that can be controlled with medications, often in an outpatient setting. With
frequent attacks, a mild exposure to a known trigger will often be sufficient to
exacerbate an attack. Patients who do not respond to medications or who use med-
ications improperly may die during an asthma attack.

SIGNS AND SYMPTOMS

• Wheezing initially present on expiration continues throughout respiratory
cycle as inflammation progresses. Air has difficulty moving through the nar-
rowed airways, making noise. Not all asthmatics will have wheezing.
• Asymptomatic between asthma attacks. Symptoms resolve when there is no
inflammation present.
• Difficulty breathing (dyspnea) as airways narrow due to inflammation. This
is typically progressive as inflammation increases.
• Respiration greater than 20 breaths per minute (tachypnea) as the body
attempts to get more oxygen into the lungs to meet physiologic needs.
• Use of accessory muscles to breathe as the body tries harder to get more air
into the lungs.
• Tightness in the chest due to narrowing of the airways (bronchoconstriction).
• Cough.
• Tachycardia—heart rate greater than 100, as the body attempts to get more
oxygen to the tissues.

TREATMENT
The focus of treatment is to return the respiratory status to normal, deliver ade-
quate oxygen, and limit the number of recurrences. Patient education should focus
on understanding the disease, its management, and when emergency care may be
necessary.
• Administer supplemental oxygen to help meet body’s needs.
• Identify and remove allergens and known triggers to avoid causing an asthma
attack.
• Give patient 3 liters/day of fluid to help liquefy any secretions.
• Administer short-acting beta2-adrenergic drugs to bronchodilate:
• albuterol, pirbuterol, metaproterenol, terbutaline, levalbuterol
• Administer long-acting beta2-adrenergic drugs to manage symptoms day to
day; keep airways open, not for acute symptoms:
• salmeterol, formoterol
• Administer leukotriene modulators to reduce local inflammatory response in
lung to reduce exacerbations; does not have immediate effect on symptoms:
• zafirlukast, zileuton, montelukast
• Administer anticholinergic drugs
• ipratropium inhaler, tiotropium handihaler
• Administer antacid, H2 blocker, or proton pump inhibitor to decrease the
amount of acid in the stomach, reducing the possibility of ulcers due to stress
of disease or medication effects.
• Antacids: aluminum hydroxide/magnesium hydroxide, calcium carbonate
• H2 blockers: ranitidine, famotidine, nizatidine, cimetidine
• Proton pump inhibitors: omeprazole, lansoprazole, esomeprazole, rabepra-
zole, pantoprazole
• Administer mast cell stabilizer to retain an early component of the initial
response to allergens, which will prevent further reactions from occurring;
this is not for acute symptoms. This is useful for pretreatment for allergen
exposure or chronic use to improve control of symptoms.
• cromolyn, nedocromil
• Administer steroids to decrease inflammation, which will help open airways;
these are not for acute symptoms:
• hydrocortisone, methylprednisolone intravenously
• beclomethasone, triamcinolone, fluticasone, budesonide, flunisolide, mo-
metasone inhalers
• prednisolone, prednisone orally
• Administer methylxanthines to assist with bronchodilation, often used when
other medications not effective:
• aminophylline, theophylline

NURSING DIAGNOSES
• Impaired gas exchange
• Ineffective airway clearance
• Ineffective tissue perfusion

NURSING INTERVENTION

• Monitor respiration: patient’s respiratory status can continue to deteriorate;
look at respiratory rate, effort, use of accessory muscles, skin color, breath
sounds.
• Place patient in high Fowler’s position to ease respirations.
• Monitor vital signs, look for changes in BP, tachycardia, tachypnea.
• Explain to the patient:
• How to use a peak flow meter.
• How to use the metered dose inhaler or dry powder and in which order to
take inhaled medication.
• Avoid exposure to allergen.
• How to recognize the early signs of asthma.
• How to perform coughing and deep-breathing exercises.